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Shefalee Amin1, Marlon Abrazado1, Molly Quinn1, Thomas W Storer1, Chi-Hong Tseng2 and Christopher B Cooper1*Abstract
Background: The effectiveness of clinic-based pulmonary rehabilitation in advanced COPD is well established, but
few data exist for less severe patients treated in alternative settings. The purpose of this study was to investigate
whether a novel, community-based exercise program (CBE) was feasible and effective for patients with moderate
COPD.
Methods: Nineteen patients with moderate COPD (mean FEV1 62%) and self-reported exercise impairment were
randomized to 12-weeks of progressive endurance and strength training at a local health club under the guidance
of a certified personal trainer, or to continuation of unsupervised habitual physical activity. Outcomes assessed at
baseline and 12 weeks included session compliance, intensity adherence, treadmill endurance time, muscle
strength, dyspnea, and health status.
Results: Compliance was 94% and adherence was 83%. Comparisons between CBE and control groups yielded the
following mean (SEM) differences in favor of CBE: endurance time 134 (74) seconds versus -59 (49) seconds (P = 0.041)
and TDI 5.1 (0.8) versus -0.2 (0.5) (P < 0.001). The CBE group increased muscle strength (weight lifted) by 11.8 kilograms
per subject per week of training (P < 0.001). SGRQ was not significantly changed.
Conclusions: We demonstrated the feasibility and effectiveness of a novel community-based exercise program
involving health clubs and personal trainers for patients with moderate COPD.
Trial registration: ClinicalTrials.gov Identifier NCT01985529.
Keywords: Community, Exercise rehabilitation moderate COPDBackground
Chronic obstructive pulmonary disease (COPD) is a pro-
gressive debilitating disease that leads to worsening symp-
toms and declining exercise capacity [1]. Progressive weight
loss is also common [2] and associated with increased mor-
tality and compromised quality of life [3]. Skeletal muscle
dysfunction is recognized to account for an appreciable
portion of the exercise impairment in COPD patients [4].
Evidence for this particular abnormality includes reduced
muscle aerobic enzyme content [5,6] and a tendency to de-
velop premature lactic acidosis during exercise [1]. Further-
more, calf muscle cross-sectional area is reduced compared
with controls [7] and muscle strength is also impaired [8].* Correspondence: CCooper@mednet.ucla.edu
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unless otherwise stated.Importantly, COPD is now regarded as preventable
and treatable [9]. One could argue that successful treat-
ment requires earlier recognition of the decline in exer-
cise performance and implementation of a structured
exercise program to reverse its deleterious effects.
Structured exercise training is strongly endorsed for
COPD in the context of a pulmonary rehabilitation pro-
gram recognizing that these programs increase func-
tional capacity, decrease symptoms, reduce utilization of
health-care resources and improve quality of life [10-12].
The Global Initiative on Obstructive Lung Disease (GOLD)
recommends that patients with COPD should be referred
for pulmonary rehabilitation once their FEV1 falls below
normal [13]. This equates to the transition from mild to
moderate disease and corresponds with the time when pa-
tients begin to significantly reduce activities of daily liv-
ing [14]. Furthermore, the American Thoracic Society/
European Respiratory Society Statement on Pulmonarytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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spiratory disease associated with diminished functional
capacity and reduced health related quality of life may
benefit from pulmonary rehabilitation [12].
While pulmonary rehabilitation is practiced as a multi-
disciplinary therapy, evidence-based analysis identifies
exercise training as the most effective component [15].
Despite guidelines, a national survey of 283 pulmonary
rehabilitation programs in 1995 identified considerable
differences in program content [16]. Lack of consistency
in the approach to aerobic and resistance training in
chronic pulmonary disease is likely to result in sub-
optimal outcomes in many cases.
A paradigm shift is needed to make exercise training
programs for COPD patients more scientifically rigorous
and cost-effective. We have studied the feasibility of a
community-based exercise program under the supervi-
sion of personal trainers appropriately certified in exercise
physiology and trained to manage pulmonary patients
safely and with confidence. We examined the hypothesis
that in patients with moderate COPD and reduced aerobic
capacity, the combination of aerobic exercise training plus
nutritional counseling would result in improvement in
exercise endurance, muscle strength, activity levels and
quality of life compared with control group having only
nutritional counseling. A secondary aim was to demon-
strate the feasibility of community-based exercise re-
habilitation delivered through health clubs and personal
trainers at an earlier stage in the progression of COPD.
Methods
Subjects
We recruited 19 men and women with moderate COPD
as defined by the GOLD [17] criteria (FEV1/FVC, % <70%;
FEV1 < 70% and >50% predicted), a 10 pack-year smokingFigure 1 Study design showing time frame and procedures at each vhistory and self-reported functional impairment. Exclusion
criteria included current smokers, pulmonary diseases
other than COPD, use of supplemental oxygen, musculo-
skeletal disease that impaired exercise performance and
unstable coronary artery disease or congestive heart fail-
ure. The study was approved by the UCLA Office for the
Protection of Research Subjects (IRB#11-000175) and all
subjects gave written informed consent.
Study design
This was a small parallel-group, randomized controlled
study to assess the feasibility of implementing a community-
based exercise program for patients with moderate
COPD (see Figure 1). At the screening visit, spirometry
was performed to assess eligibility in terms of the
GOLD staging followed by body plethysmography, dif-
fusing capacity and a maximal, symptom-limited, incre-
mental exercise test on a treadmill ergometer using a
standardized protocol [18]. Then, after a resting period of
2 hours, they performed a constant work-rate exercise test
at 90% of the maximum work rate calculated from the in-
cremental test.
Within two weeks of the screening visit, subjects
returned to repeat the constant work-rate exercise test
also on a treadmill at the same constant work rate as at
the first visit. This was intended to overcome any learn-
ing effect, and the best value for endurance time from
the two constant load tests was used for future compari-
son. Subjects had assessments of body composition, dys-
pnea (Baseline Dyspnea Index, BDI) and quality of life
(St. George’s Respiratory Questionnaire, SGRQ) [19,20].
Although not felt to be malnourished, all subjects were
given nutritional guidance from a certified nutritionist
by way of best clinical practice and also so as to be able
to offer some benefit to those subjects randomized toisit.
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on a Food Frequency Questionnaire [21] administered
every two months to assess diet and specifically to ascer-
tain the habitual protein intake of the subject. Detailed,
written recommendations were then given on an individ-
ualized basis with the goal of achieving a daily protein
intake of 1.5 g per kilogram of body weight plus a daily
energy intake of 35 kilocalories per kilogram of body
weight.
Subjects were then randomized 1:1 into two groups:
(a) community based exercise program (CBE) or (b)
usual habitual activity (control). Both groups continued
standard COPD management based on published guide-
lines and appropriate for the stage of their disease. Subjects
randomized to exercise training had measures of lower ex-
tremity strength by 1-repetition maximum (1-RM) for leg
press at the time of the first training session. At 12 weeks,
all patients were asked to repeat baseline measurements.
Minor exacerbations, defined as an increase in two or
more symptoms (dyspnea, sputum volume and sputum
purulence) for three or more days [22] but not requiring
hospitalization, were referred to the subjects’ primary
care physician for intensification of bronchodilator ther-
apy and/or an antibiotic. Details of minor exacerbations
were recorded but subjects continued in the study.
Major exacerbations, requiring use of systemic cortico-
steroids or hospital admission, resulted in withdrawal
from the study.
Community-based exercise program
Following randomization, those subjects assigned to the
exercise program were assigned to a personal trainer op-
erating out of one of three local health clubs. They met
at mutually convenient times, twice per week for
12 weeks. Each of the clubs provided facilities for aer-
obic exercise and resistance training. Two facilities pro-
vided two trainers each and a fifth trainer was in solo
practice. All five trainers possessed Bachelors and/or
Masters degrees in exercise science or related fields. Three
were -Certified Strength and Conditioning Specialist
(CSCS) from the National Strength and Conditioning As-
sociation and two held Exercise Specialist certifications
from the American College of Sports Medicine. Specific
methodologies were thoroughly reviewed with each per-
sonal trainer prior to the study along with general infor-
mation regarding COPD and its effects on exercise
tolerance and physical function. Initial, individualized aer-
obic and exercise prescriptions were developed for each
subject based on findings from the maximal incremental
exercise test performed at the screening visit. Information
derived from this test was also used to define a safe ceiling
for exercise intensity for each individual subject.
Each session included a warm-up and cool-down period.
Subjects then performed 30 minutes of continuous aerobicexercise in the target heart rate range based upon an initial
exercise prescription developed by the investigators. The
trainers were entrusted with progressing the exercise pre-
scription at reinforcement visits in order to maintain the
appropriate exercise intensity. Subjects also performed re-
sistance training designed upon basic principles, starting
with one set of each of eight conventional free-weight or
machine-based exercises for the large muscle groups of the
upper and lower body and progressing to two sets (typic-
ally after 10-12 sessions) at the discretion of the personal
trainer. The stipulated goal was to maintain 12 repetitions
of each exercise in correct form before muscle fatigue
(typically 70-75% of the maximal 1-RM weight).
Subjects assigned to the control group were told to
continue their activities of daily living. They were con-
tacted by telephone every month to see assess their
progress.Outcomes
The co-primary outcome measures were endurance time
for the constant work rate exercise test and change in
muscle strength as calculated by total weight lifted per
week. Secondary outcomes were lean body mass, per-
centage body fat, dyspnea (Transition Dyspnea Index,
TDI) and SGRQ. Compliance was calculated as the per-
centage of sessions attended (out of 24), and adherence
was calculated as the percentage of time subjects spent
exercising in or above their target heart rate zone.Statistical analysis
The sample size for this study was estimated using an
anticipated effect size for change in exercise endurance
time derived from experience with bronchodilator ther-
apy and other interventions in COPD patients. For ex-
ample, acute administration of inhaled ipratropium
bromide increased endurance time by 1.1-2.8 minutes
and more recent work with the long-acting bronchodila-
tor tiotropium bromide increased exercise endurance
time for a similar work rate protocol by 105 seconds
compared with placebo [23]. Importantly, changes in en-
durance time of this magnitude were felt to be associated
with clinically meaningful perceptions of improvement on
the part of the investigators and the patients. In a study of
repeated constant work rate exercise testing in severe
COPD patients (FEV1 = 40%) in clinically stable state,
O’Donnell et al [24] showed that exercise endurance time
was highly reproducible with a standard deviation of
60 seconds. From our database of submaximal CWR tests
in moderate COPD patients repeated during the same
week, we found a standard deviation for endurance time
of 88 seconds. Our power analysis, based on a standard
deviation of 88 seconds, α = 0.05 and 10 subjects in each
group indicates a power of 86% (β = 0.14) to detect a
Table 1 Baseline characteristics of the control and
community-based exercise groups
Control group CBE group
No. of subjects 10 9
Age (year) 72.0 (10.1) 66.8 (8.1)
Male sex (%) 60 33
Height (m) 1.70 (0.1) 1.72 (0.1)
Weight (kg) 76.2 (10.9) 76.6 (23.4)
FEV1 (%) 60.8 (10.9) 63.6 (7.6)
Resting heart rate (/min) 82.7 (8.3) 76.4 (9.9)
O2 saturation (%) 96 (2) 96 (2)
BDI 6.5 (0.6) 6.6 (0.9)
Body fat (%) 27.1 (8.2) 32.5 (3.1)
Lean body mass (kg) 55.8 (10.4) 56.4 (16.7)
Values are mean (standard deviation). FEV1: forced expiratory volume in one
second. O2 saturation: oxygen saturation. BDI: Baseline Dyspnea Index. m: meters.
s: seconds. kg: kilograms.
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groups after 3 months.
We used a two-sample t-test to evaluate whether exer-
cise endurance time was longer in the subjects treated
with exercise training and nutritional counseling versus
nutritional counseling alone. We also carried out regres-
sion analysis to adjust for baseline covariates including
age, gender and habitual activity level. Similar statistical
methods as employed for the primary outcome measure
were also applied to compare body mass index, TDI and
SGRQ between groups.
Results
Between August 2008 and December 2010, 29 patients
were consented for the trial. Five patients failed screen-
ing. Twenty-four patients were randomized. Five pa-
tients in the exercise group withdrew from the study
after randomization (one with worsening knee pain, one
with an unrelated ankle injury, one with exacerbation of
COPD, one with newly diagnosed lung cancer and one
who was lost to follow-up). The baseline characteristics
for both the control and exercise groups are listed in




Endurance time (s) 408 (67) 350 (89) -59
SGRQ total score 35.1 (3.8) 34.4 (6.2) -0.7
TDI focal score NA -0.2 (0.5) -0.2
Total weight lifted (kg/week) NA NA NA
Values are mean (SEM). SGRQ: St. George’s Respiratory Questionnaire. TDI: Transition
NA: not applicable.anthropometrics, body composition, resting pulmonary
function and breathlessness. The average FEV1 of all
subjects was 62%, indicating moderate severity of COPD.
Those randomized to the exercise group completed 202
of 216 total sessions, resulting in 94% compliance with
the CBE. These subjects performed endurance exercise
in or above the prescribed target heart rate zone 83% of
the time.
As shown in Table 2 and Figure 2, at the end of
12 weeks, endurance time increased 134 seconds in the
CBE group and decreased 59 seconds in the control
group (P = 0.041). Patients who participated in the CBE
arm lifted significantly more weight at the end of the ex-
ercise program compared with the beginning as shown
in Figure 3: 3432 versus 1775 kilograms (P < 0.001). This
represents a 93% overall improvement over 12 weeks,
averaging an increase of 11.8 kilograms of weight lifted
per subject for every week of exercise training. Figure 4
shows that SGRQ total scores decreased by 0.7 in the
control group and 4.6 in the CBE group (P = 0.611).
Whilst the differences between groups were not signifi-
cant, the average fall in SGRQ total score within the ex-
ercise training group exceeds the MCID of 4 units which
was not the case with the control group. TDI focal score,
shown in Figure 5, increased by 5.1 in the CBE group
versus a decrease of 0.2 in the control group, indicating
less breathlessness (P < 0.001). There was no difference
in body composition as determined by skin folds be-
tween the CBE and control group after intervention
(change in body fat -1.1% versus -0.1%, P = 0.285; change
in lean body mass +1.2 kilograms versus +0.1 kilograms,
P = 0.206).
Discussion
We successfully conducted this small, randomized, feasi-
bility study of a community-based exercise program ver-
sus habitual activity in patients with moderate COPD.
We found increases in exercise endurance time and
muscle strength, along with improved health-related
quality of life, and reduced dyspnea in those who under-
went exercise training compared to those who received
nutritional counseling only. The average improvement inyspnea in control patients versus those in the
CBE group P-value
ge Pre Post Change
444 (121) 578 (147) +134 0.041
32.1 (5.4) 27.6 (4.6) -4.6 0.611
NA 5.1 (0.8) +5.1 <0.001
1775 (303) 3432 (361) +1657 <0.001
al Dyspnea Index. s: seconds. Kg/wk: kilograms per week.
Figure 2 Mean treadmill endurance times for the two groups at baseline and after 12 weeks. Mean changes were a decrease of
59 seconds for the control group compared with an increase of 134 seconds for those completing the community-based exercise program (P = 0.041).
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rate at baseline which compares favorably with changes in
endurance time between 100 and 120 seconds in thera-
peutic trials of inhaled bronchodilators [23,25-27]. Further-
more, compliance and adherence to this community-based
exercise program surpassed published rates for clinic- or
hospital-based exercise programs [28].
We were unable to demonstrate a statistically signifi-
cant and clinically meaningful difference in health status
between the two groups as measured by SGRQ total
score. There are likely two reasons for this: (1) with rela-
tively small numbers of subjects the study was underpow-
ered to prove the SGRQ changes statistically significant
and (2) the difference between the groups was narrowed
by a Hawthorne effect in the control group. Taking intoFigure 3 Changes in total weight lifted for individual subjects
from baseline to completion of training. Total weight lifted per
week is calculated as the product of load (kilograms) × repetitions ×
sets for two days in week one and two days at end of study. Diagonal
lines represent individual changes. Horizontal lines represent group
means and error bars are SEM (P < 0.001).account these shortcomings of our analysis, we feel that
the reduction of SGRQ of -4.6 units in the training group
is likely a real effect and brings our results, in terms of the
effects of an exercise program on health status, into better
alignment with the results of other studies.
Other studies on community based exercise programs
have demonstrated improvements in functional capacity,
dyspnea, and disease specific quality of life [29-32].
However, these studies have focused on patients with se-
vere COPD (FEV1 < 50%) whereas our subjects were less
severe (mean FEV1 62%). We specifically sought to fol-
low GOLD [33] and ATS/ERS [12] guidelines by recruit-
ing patients with less severe disease. We reasoned that
these patients would find a community-based exercise
program, close to their home or workplace, more con-
venient than the typical clinic-based or hospital-based
program. We also surmised that less severe patients
would feel comfortable exercising in a health club envir-
onment alongside apparently normal individuals. The
compliance with recommended training sessions of 99%
attests to the success of this strategy. Furthermore,
knowing that supervised exercise training is significantly
more successful than unsupervised training, we utilized
personal trainers to improve subject adherence to exer-
cise prescriptions. The 83% adherence to the target heart
rate range for aerobic training is impressive and clearly
associated with marked improvements in the prespeci-
fied outcome measures of exercise performance.
We are aware of two other studies that examined out-
patient rehabilitation in patients with moderate COPD.
Cambach et al [34] found improved exercise tolerance
and quality of life in patients with moderate COPD after
6 months of rehabilitation, however, this sample of
Figure 4 Mean SGRQ scores for the two groups at baseline and after 12 weeks. Mean changes were a decrease of 0.7 for the control group
and a decrease of 4.6 for those completing the community-based exercise program (P = 0.611). Decreased scores represent improvement in quality of
life where a change of 4.0 is considered clinically meaningful.
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might have been more fluctuant. Additionally, this re-
habilitation program was conducted in various medical
practices under the guidance of clinically trained physio-
therapists, rather than in a local health club with certified
personal trainers as in our community-based program. In
another study, van Wetering, et al [35] randomized 199
patients with moderate COPD (mean FEV1 60%) to an
interdisciplinary community-based COPD management
program (INTERCOM) or usual care. This study was con-
ducted in the Netherlands where community-based phys-
ical therapists can be assigned to visit patients in theirFigure 5 Mean TDI focal score for the two groups after 12 weeks. Me
increase of 5.1 for those completing the community-based exercise progra
where a change of 1.0 is considered clinically meaningful.homes. The investigators reported improvements in health
related quality of life, breathlessness, exercise perform-
ance, muscle strength, and body composition, but were
unable to show improvements in muscle strength. Al-
though this rehabilitation program was conducted in the
community, it utilized clinically trained physical therapists
and other medical personnel. Despite the promising data
in favor of community based rehabilitation programs, it
remains clear that there is not yet any consensus regarding
the ideal structure for such programs. The traditional
medical model of pulmonary rehabilitation is focussed
on exercise encouragement in more severely disabledan changes were a decrease of 0.2 for the control group and an
m (P < 0.001). Increased scores represent improvement in dyspnea
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dyspnea and modest gains in exercise performance are
considered acceptable. Our program is the first to use
certified personal trainers, based in health clubs, which
are becoming increasingly prevalent in the community.
This health club model is more directed to maximizing
performance using basic principles of reconditioning and
muscle strengthening. Whilst there is undoubtedly consid-
erable overlap in these approaches, we think that the per-
sonal trainers can potentially bring a new dimension to
pulmonary rehabilitation.
The major limitation of our study was its small size.
However, this was a pilot study and one of the main pur-
poses was to demonstrate the feasibility of CBE training
in moderate COPD. Our results should prompt further
research to standardize procedures and define optimal
interventions. A further limitation is that, although sub-
jects were randomly assigned to two groups (exercise
training or usual physical activities), the individual sub-
jects and the trainers obviously could not be blinded to
their treatment allocation. We attempted to reduce ob-
server bias by having the baseline and final assessments
performed in the research laboratory, distant from the
training location, with the technician blinded and specif-
ically instructed not to inquire about group allocation.
Our exercise program was novel, but there was incom-
plete standardization of the exercise facilities involved in
the study and the variability in the training and experi-
ence of the personal coaches. The exercise facilities
included a nationally distributed chain, a small privately-
owned facility, and a large privately-owned facility. The
exercise coaches were all certified personal trainers and
they received an educational session and information on
exercise limitations in COPD patients. A future study
might attempt to standardize the approach to training
even further.
Conclusions
In summary, our data confirm that community based ex-
ercise programs are not only feasible, but also effective,
in patients with moderate of COPD. Such programs im-
prove functional capacity, dyspnea, and health related
quality of life, and should therefore be considered in the
routine management of these patients. Furthermore, our
findings contribute to a growing body of evidence that
calls for a paradigm shift in the philosophy of pulmonary
rehabilitation. As a treatment strategy, community-based
exercise programs should be introduced earlier in the
progression of COPD so as to forestall the development
of comorbidities associated with the lack of regular exer-
cise and deconditioning. Future efforts should be made to
establish uniform guidelines to ensure that community-
based exercise training programs for COPD patients are
scientifically rigorous and cost-effective.Abbreviations
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